Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.

Bonkhoff H.

Prostate. 2018 Jan;78(1):2-10. doi: 10.1002/pros.23446. Epub 2017 Nov 2. Review.

PMID:
29094395
2.

Significance of prostate cancer missed on needle biopsy tools for retrieving missed cancer.

Bonkhoff H.

Prostate. 2016 Mar;76(4):369-75. doi: 10.1002/pros.23128. Epub 2015 Nov 30.

PMID:
26616257
3.

Reliable identification of transition zone prostatic adenocarcinoma in preoperative needle core biopsy.

Lee S, Walsh S, Woods CG, Bonkhoff H, Cohen RJ.

Hum Pathol. 2013 Oct;44(10):2331-7. doi: 10.1016/j.humpath.2013.05.015. Epub 2013 Aug 16.

PMID:
23954139
4.

Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?

Bonkhoff H, Wheeler TM, van der Kwast TH, Magi-Galluzzi C, Montironi R, Cohen RJ.

Prostate. 2013 Mar;73(4):442-8. doi: 10.1002/pros.22579. Epub 2012 Sep 4. Review.

PMID:
22949099
5.

Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.

Bonkhoff H.

Prostate Cancer. 2012;2012:593241. doi: 10.1155/2012/593241. Epub 2011 Sep 8.

6.

From pathogenesis to prevention of castration resistant prostate cancer.

Bonkhoff H, Berges R.

Prostate. 2010 Jan 1;70(1):100-12. doi: 10.1002/pros.21042. Review.

PMID:
19760632
7.

The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.

Bonkhoff H, Berges R.

Eur Urol. 2009 Mar;55(3):533-42. doi: 10.1016/j.eururo.2008.10.035. Epub 2008 Nov 6. Review.

PMID:
19013008
8.

A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.

Cohen RJ, Wheeler TM, Bonkhoff H, Rubin MA.

Arch Pathol Lab Med. 2007 Jul;131(7):1103-9. Review.

PMID:
17616999
9.
10.

[Gleason grading: diagnostic criteria and clinical implications].

Bonkhoff H.

Pathologe. 2005 Nov;26(6):422-32. German.

PMID:
16215708
11.

[Prognostic factors in prostate cancer].

Bonkhoff H.

Pathologe. 2005 Nov;26(6):433-43. German.

PMID:
16205900
12.

[Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry].

Bonkhoff H.

Pathologe. 2005 Nov;26(6):405-21. Review. German.

PMID:
16205899
13.

[Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype].

Bonkhoff H, Fixemer T.

Pathologe. 2005 Nov;26(6):453-60. German.

PMID:
16195860
14.

Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach.

Luebke AM, Schlomm T, Gunawan B, Bonkhoff H, F├╝zesi L, Erbersdobler A.

Virchows Arch. 2005 Mar;446(3):338-41. Epub 2005 Feb 22.

PMID:
15726402
15.

TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression.

Wissenbach U, Niemeyer B, Himmerkus N, Fixemer T, Bonkhoff H, Flockerzi V.

Biochem Biophys Res Commun. 2004 Oct 1;322(4):1359-63. Review.

PMID:
15336984
16.

[Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].

Bonkhoff H, Fixemer T.

Urologe A. 2004 Jul;43(7):836-42. Review. German.

PMID:
15048555
17.

[New insights into the role of estogens and their receptors in prostate cancer].

Bonkhoff H, Motherby H, Fixemer T.

Urologe A. 2003 Dec;42(12):1594-601. Review. German.

PMID:
14668987
18.

Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.

Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H.

Oncogene. 2003 Oct 30;22(49):7858-61.

PMID:
14586412
19.

Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.

Kamradt J, Drosse C, Kalkbrenner S, Rohde V, Lensch R, Lehmann J, Fixemer T, Bonkhoff H, Stoeckle M, Wullich B.

Lab Invest. 2003 May;83(5):623-33.

PMID:
12746472

Supplemental Content

Loading ...
Support Center